Central Trust Company’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50
| Closed | -$260 | – | 1521 |
|
|
2024
Q3 | $260 | Hold |
50
| – | – | ﹤0.01% | 1387 |
|
|
2024
Q2 | $129 | Hold |
50
| – | – | ﹤0.01% | 1403 |
|
|
2024
Q1 | $246 | Hold |
50
| – | – | ﹤0.01% | 1359 |
|
|
2023
Q4 | $440 | Hold |
50
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q3 | $574 | Hold |
50
| – | – | ﹤0.01% | 1336 |
|
|
2023
Q2 | $1.27K | Hold |
50
| – | – | ﹤0.01% | 1191 |
|
|
2023
Q1 | $1.61K | Hold |
50
| – | – | ﹤0.01% | 1200 |
|
|
2022
Q4 | $923 | Hold |
50
| – | – | ﹤0.01% | 1204 |
|
|
2022
Q3 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 1285 |
|